Melanie Wapelhorst
About Melanie Wapelhorst
Melanie Wapelhorst is the Implementation Strategy Lead and Learning Manager at Bristol-Myers Squibb in New Jersey, United States. She has extensive experience in the healthcare and pharmaceutical industries, particularly in patient recruitment and engagement strategies.
Current Roles at Bristol-myers Squibb
Melanie Wapelhorst is currently serving as the Implementation Strategy Lead at Bristol-myers Squibb in New Jersey, United States. She is also taking on responsibilities as a Learning Manager within the same organization. Her roles involve critical functions in implementation strategy and learning management, contributing to the broader mission of the company in the healthcare and pharmaceutical sectors.
Previous Role at Authentidate Holding Corp
From 2009 to 2011, Melanie Wapelhorst worked at Authentidate Holding Corp. as the Director of Physician Services. In this capacity, she managed various physician-related services, leveraging her expertise to streamline operations and enhance service delivery during her two-year tenure.
Experience with Cardinal Health
Between 2005 and 2009, Melanie Wapelhorst was employed as a Product Management Training Specialist at Cardinal Health in Dublin, Ohio, United States. During her four years with the company, she played a significant role in training and product management, contributing to the growth and efficacy of Cardinal Health's initiatives.
Production Management at Jack Morton Worldwide
From 2000 to 2003, Melanie Wapelhorst served as a Production Manager at Jack Morton Worldwide in Boston, Massachusetts, United States. She was responsible for overseeing production operations, ensuring that projects were completed on time and to the standards required by the organization.
Education at University of Pittsburgh
Melanie Wapelhorst studied at the University of Pittsburgh from 1986 to 1991. During her five years at the institution, she honed the foundational skills and knowledge that would support her varied roles in the healthcare and pharmaceutical industries.